Potential Polyvaccine Based on Microbial IgA1 Protease for Prophylaxis of Bacterial Meningitis

Potential Polyvaccine Based on Microbial IgA1 Protease for Prophylaxis of Bacterial Meningitis

The immunogenic and protective activities of recombinant IgA1 serine protease obtained on the base of the genome DNA of N. meningitidis serogroup B strain H44/76 were studied. A several recombinant proteins of different molecular weights that are based on the full-length primary structure of the enz...

Full description

Bibliographic Details
Main Authors:	A. P. Alliluev, O. V. Kotelnikova, A. A. Zinchenko, Yu. A. Prokopenko, L. S. Zhigis, O. A. Razgulyaeva, T. D. Melikhova, E. A. Nokel, E. Yu. Drozhzhina, L. D. Rumsh
Format:	Article
Language:	Russian
Published:	Numikom LLC 2016-12-01
Series:	Эпидемиология и вакцинопрофилактика
Subjects:	менингококковая поливакцина igal-протеаза рекомбинантные белки иммуногенность протективность meningococcal polyvaccine iga1 protease recombinant proteins immunogenicity protectivity
Online Access:	https://www.epidemvac.ru/jour/article/view/220

Similar Items

Current State of Cholera Specific Prophylaxis
by: I. A. Bespalova, et al.
Published: (2018-02-01)

Enhancement of the Yersinia pestis EV NIIEG Vaccine Srain Immunogenic and Protective Activity under Cultivation with Azoxymer Bromide (Polyoxidonium)
by: T. N. Shchukovskaya, et al.
Published: (2022-01-01)

Antigenic properties estimation for legumain protein recombinant analogue of trematoda Opisthorchis felineus, causing human opisthorchiasis
by: I. A. Razumov, et al.
Published: (2012-12-01)

Meningococcal vaccine. From capsular polysaccharides of microbes to proteases
by: A P Alliluyev, et al.
Published: (2012-12-01)

World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)
by: I. S. Koroleva, et al.
Published: (2022-01-01)

Strengthening the Effectiveness of the Candidate Influenza Vaccine by Combining Conserved Sequences of Hemagglutinin and M2 protein
by: L. M. Tsybalova, et al.
Published: (2017-06-01)

DETERMINATION OF POLYSORBATES BY SPECTROPHOTOMETRY IN DRUGS BASED ON RECOMBINANT PROTEINS
by: A. D. Askretkov, et al.
Published: (2019-01-01)

Immunogenic Properties Studyoffusion Recombinant Proteins Based on VP6 and VP8 of Human Rotavirus A
by: I. V. Dukhovlinov, et al.
Published: (2015-04-01)

Highly Similar Sequences of Mature IgA1 Proteases from <i>Neisseria meningitidis</i>, <i>Neisseria gonorrhoeae</i> and <i>Haemophilus influenzae</i>
by: David Karlinsky, et al.
Published: (2022-06-01)

Cloning and expression of African swine fever virus K205R and B602L genes inf. COLI
by: A. V. Scherbakov, et al.
Published: (2018-04-01)

Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

The Susceptibility of Meningococci to the Antimicrobial Agents in Moscow 2006 - 2015
by: M. A. Koroleva, et al.
Published: (2016-06-01)

Monoclonal Antibodies and Recombinant Proteins for Immune-Diagnostics of Ebola Virus Disease
by: E. I. Kazachinskaya, et al.
Published: (2015-09-01)

New recombinant T. pallidum antigens Tp0453 and Tp0319 in the diagnostics of syphilis
by: A. V. Runina, et al.
Published: (2017-08-01)

Safety of Combination of a Tetravalent Meningococcal Conjugate Vaccine Against Serogroups A, C, Y, W-135 With Other Vaccine Preparations: a Prospective Study of a Series of Cases Among Healthy Children and Children With Various Health Abnormalities
by: Leyla S. Namazova-Baranova, et al.
Published: (2017-06-01)

Use of p30,pK205R and pB602L recombinant proteins for African swine fever serodiagnosis
by: M. R. Yakupov, et al.
Published: (2018-04-01)

HEAT SHOCK PROTEIN HSP70: PREREQUISITES FOR USE AS A MEDICINAL PRODUCT
by: V. M. Pokrovsky, et al.
Published: (2021-10-01)

The Investigation of the Prospects for Using NS4A Antigen of Hepatitis C Virus for the Development of Recombinant Mosaic Vaccines with Self-Adjuvant Properties
by: V. V. Koupriyanov, et al.
Published: (2017-02-01)

Meningococcal infection in children: factors influencing outcome
by: O. V. Samodova, et al.
Published: (2019-10-01)

Clinical and epidemiological aspects of generalized meningococcal infections in children and adolescents of Saint-Petersburg
by: Yu. V. Lobzin, et al.
Published: (2016-04-01)

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) in Children 9–23 Months of Age in Russian Federation: Results of Russian Part of International Study in Russia and India
by: O. A. Perminova, et al.
Published: (2020-05-01)

Meningococcal Infection in Novosibirsk: Changes in Epidemiology and Prevention Problems
by: I. Ya. Izvekova, et al.
Published: (2021-07-01)

The Level of Meningococcal Carriage and Genotyping of N. meningitidis Strains in the Group of Labor Migrants
by: M. A. Koroleva, et al.
Published: (2020-11-01)

Herpesviruses, as a possible cause complicated course of invasive meningococcal disease (clinical case)
by: N. V. Skripchenko, et al.
Published: (2016-07-01)

Clinical-epidemiological features of meningococcal infection in children during sporadic morbidity
by: G. P. Martynova, et al.
Published: (2015-07-01)

Development and Validation of the ELISA Method for Anti-trastuzumab Antibodies Determination in Human Serum
by: O. A. Eliseeva, et al.
Published: (2022-12-01)

Influence of salt structure on a level of activity of digestive enzymes of a carp
by: V. I. Egorova
Published: (2015-02-01)

Immunogenicity Assessment of Pegfilgrastim in Patients with Breast Cancer
by: Yu. V. Medvedev, et al.
Published: (2020-05-01)

HOMOLOGY BETWEEN SEGMENTS OF HUMAN HEMOSTATIC PROTEINS AND PROTEINS OF VIRUSES WHICH CAUSE ACUTE RESPIRATORY INFECTIONS OR DISEASES WITH SIMILAR SYMPTOMS
by: I. N. Zhilinskaya, et al.
Published: (2017-10-01)

POST-VACCINATION IMMUNE RESPONCE IN SERONEGATIVE TO INFLUENZA VIRUS HIV-INFECTED PATIENTS
by: R. G. Yapparov, et al.
Published: (2018-04-01)

The Safety of 4-valent Meningococcal Conjugate Vaccine in Two Years Old Children: Prospective Cohort Study in Sakhalin Region
by: Oxana V. Solonina, et al.
Published: (2019-09-01)

Construction and Investigation of the Variants of the Vaccine Strain <I>Francisella tularensis</I> Lacking <I>iglC </I>Genes. Communication 2
by: A. N. Mokrievich, et al.
Published: (2013-12-01)

Characteristics of an extraembrional structures of women suffered from chronic anemia
by: V E Radzinskii, et al.
Published: (2011-12-01)

КОМОРБИДНОСТЬ ПРИ ХРОНИЧЕСКОЙ ПЕРСИСТЕНЦИИ ГЕРПЕТИЧЕСКОЙ ИНФЕКЦИИ: КОМПЛЕКСНЫЕ ПОДХОДЫ К ЛЕЧЕНИЮ БОЛЬНЫХ
by: Ирина Анатольевна Горбачева, et al.
Published: (2020-10-01)

Economic prognosis from vaccination against meningococcal infection inclusion into the National calendar of prophylactic vaccines in children of first age old
by: L. D. Popovich, et al.
Published: (2022-08-01)

INVESTIGATION OF A ROLE OF THE IMMUNOGENICITY OF INFLIXIMAB IN THE THERAPY OF ANKYLOSING SPONDYLITIS
by: O. A. Rumyantseva, et al.
Published: (2016-09-01)

Specific features of sensitization to recombinant peanut allergens in children with anaphylaxis
by: A. M. Shulyaeva, et al.
Published: (2016-09-01)

Systemic meningococcal disease in children: survival analysis, Arkhangelsk region, Northwest Russia, 1991–2011
by: O. V. Samodova, et al.
Published: (2014-09-01)

An economic evaluation of vaccination in children against meningococcal infection in Moscow
by: S. V. Svetlichnaya, et al.
Published: (2023-10-01)

Negative impact of chronic pyelonephritis on the gestation
by: A A Orazmuradov, et al.
Published: (2011-12-01)